Eton Pharmaceuticals, Inc.
USD37.33
+0.59 (+1.62%)
CEO
Sean E. Brynjelsen
IPO Date
2018-11-14
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$36.74
Prev. Close
$36.73
Day Low
$36.26
Day High
$37.50
52W Low
$13.51
52W High
$37.49
Market Cap
$1.02B
Volume
0.16M
| -90.2 |
| 31 Dec 2023 | FY | 66.6% | -3.0% | -6.0% | -2.9% | 0.35 | 1.65 | -120.0 |
| 31 Dec 2022 | FY | 67.4% | -42.4% | -69.0% | -36.0% | 0.50 | 3.10 | -7.9 |
| 31 Dec 2021 | FY | 88.0% | -9.0% | -11.1% | -7.1% | 0.38 | 5.18 | -55.3 |
| 31 Dec 2020 | FY | -633.3% | -71717.9% | -178.6% | -106.3% | 0.46 | 6.51 | -6.1 |
| 31 Dec 2019 | FY | 52.8% | -1910.3% | -173.6% | -107.3% | 0.43 | 7.65 | -7.0 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -48.4% | -45.0% | 0.00 | 13.59 | -3.1 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -59.0% | -53.2% | 0.00 | 16.76 | -15.2 |
| 76.7 |
| 30 Sept 2025 | Q3 | 35.0% | -8.6% | -8.3% | -1.8% | 0.14 | 1.63 | -75.8 |
| 30 Jun 2025 | Q2 | 63.0% | -13.7% | -10.8% | -2.5% | 1.28 | 1.77 | -37.1 |
| 31 Mar 2025 | Q1 | 57.1% | -9.1% | -6.4% | -1.9% | 1.23 | 1.97 | -55.5 |
| 31 Dec 2024 | Q4 | 55.6% | -5.1% | -2.4% | -0.8% | 1.22 | 2.06 | -145.5 |
| 30 Sept 2024 | Q3 | 61.0% | 6.1% | 3.9% | 1.7% | 0.27 | 1.51 | 62.0 |
| 30 Jun 2024 | Q2 | 62.0% | -33.5% | -22.6% | -9.6% | 0.36 | 1.40 | -7.2 |
| 31 Mar 2024 | Q1 | 62.9% | -10.2% | -5.2% | -2.6% | 0.33 | 1.59 | -29.8 |
| 31 Dec 2023 | Q4 | 49.6% | -30.8% | -14.6% | -7.1% | 0.35 | 1.65 | -12.5 |